Short answer: There isn’t a publicly disclosed exact “production cost” for olmesartan medoxomil. The cost depends on scale, location, GMP vs non-GMP requirements, grade (bulk API vs finished pharmaceutical-grade), and the specific supplier’s process and yields.
Key cost drivers to consider
- Raw materials and reagents: costs of starting materials, catalysts, solvents, and any specialized reagents.
- Process yield and efficiency: higher yields and fewer purification steps lower the per-kilo cost; complex purification (e.g., extensive crystallization, chromatography) raises it.
- GMP manufacturing and QA/QC: compliance, analytical methods, batch release testing, stability studies, and documentation.
- Capital and overhead: facility depreciation, utilities, equipment maintenance, and labor.
- Purification and quality control: spectroscopic/analytical testing, impurity profiling, and outsourcing of certain tests.
- Packaging, labeling, and stability studies if you’re talking about API form factors for formulation.
- Regulatory and IP considerations: licensing, patents (if any), and audits.
- Location and scale: labor costs, energy costs, and local regulatory costs vary by country; larger scale generally lowers per-unit cost.
A rough, non-guaranteed ballpark
- For a mid-to-high complexity small-molecule API like olmesartan medoxomil, bulk API market quotes (price to buyers, not exact production cost) can be in the low-to-mid thousands of USD per kilogram, depending on lot size and grade. The actual GMP production cost per kilogram would be influenced by the factors above and can vary widely. In any case, exact numbers require quotes from Contract Manufacturing Organizations (CMOs) or suppliers.
If you’re budgeting or evaluating a project
- The best approach is to obtain quotes from several CMOs with your specific specs (target purity, salt/form, required GMP level, annual volume, and regulatory needs).
- I can help you sketch a simple cost model if you share: desired annual production volume (kg/year), target purity/grade, whether you need a prodrug (medoxomil) form or the active, and your approximate location or region.
Would you like me to help you build a basic cost-model template or draft a set of questions to send to potential CMOs for quotes? If you provide approximate annual volume and location, I can tailor the framework and give a more concrete example.